Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-05-10

Clinical Trial Update: Relative Bioavailability Study of One Amlodipine 10mg Tablet and One Rosuvastatin 20mg Tablet to Two Fixed Dose Combinations of Amlodipine (10mg) and Rosuvastatin (20mg) in Healthy Subjects Under Fasting Conditions [Phase 1]

View source ↗

Summary

Phase 1 relative bioavailability study comparing one amlodipine 10 mg + rosuvastatin 20 mg combination tablet to two fixed-dose combination tablets of amlodipin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Amlodipine (amlodipine)
  • Rosuvastatin (rosuvastatin)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hypertension | Phase 1 | Status: COMPLETED